Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1/2, Multicentre, Open-Label, Dose Escalation and Expansion Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of SL-28 in Patients With Advanced Solid Tumours

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07341737
Title field or adapter rule
{'original_value': 'A Phase 1/2, Multicentre, Open-Label, Dose Escalation and Expansion Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of SL-28 in Patients With Advanced Solid Tumours', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At
2026-10-31T23:27:25.834255+00:00
Published At
2026-09-15T00:00:00+00:00
Record Updated At
2026-09-15
Source Retrieved At
2026-10-31T22:17:56.788771+00:00
Timestamp Basis
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation
ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Head \u0026 Neck Cancer", "Pancreas Carcinoma", "Pancreas Cancer, Metastatic", "Lung Adenocarcinoma", "Lung Cancer (NSCLC)", "Lung Cancer (Non-Small Cell)", "Esophageal Cancer", "Stomach (Gastric) Cancer", "Liver Cancer", "Intestinal Cancer", "Bladder Cancer", "Renal Cancer", "Prostate Cancer", "Melanoma (Skin Cancer)", "Breast Cancer", "Ovarian Cancer", "Endometrial Cancer", "Colorectal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct
{"date": "2026-09-15", "type": "ACTUAL"}
protocolSection.identificationModule.nctId
"NCT07341737"
protocolSection.identificationModule.officialTitle
"A Phase 1/2, Multicentre, Open-Label, Dose Escalation and Expansion Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of SL-28 in Patients With Advanced Solid Tumours"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["PHASE1", "PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct
null

Study condition terms

  • Head & Neck Cancer (protocolSection.conditionsModule.conditions)
  • Pancreas Carcinoma (protocolSection.conditionsModule.conditions)
  • Pancreas Cancer, Metastatic (protocolSection.conditionsModule.conditions)
  • Lung Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Lung Cancer (NSCLC) (protocolSection.conditionsModule.conditions)
  • Lung Cancer (Non-Small Cell) (protocolSection.conditionsModule.conditions)
  • Esophageal Cancer (protocolSection.conditionsModule.conditions)
  • Stomach (Gastric) Cancer (protocolSection.conditionsModule.conditions)
  • Liver Cancer (protocolSection.conditionsModule.conditions)
  • Intestinal Cancer (protocolSection.conditionsModule.conditions)
  • Bladder Cancer (protocolSection.conditionsModule.conditions)
  • Renal Cancer (protocolSection.conditionsModule.conditions)
  • Prostate Cancer (protocolSection.conditionsModule.conditions)
  • Melanoma (Skin Cancer) (protocolSection.conditionsModule.conditions)
  • Breast Cancer (protocolSection.conditionsModule.conditions)
  • Ovarian Cancer (protocolSection.conditionsModule.conditions)
  • Endometrial Cancer (protocolSection.conditionsModule.conditions)
  • Colorectal Cancer (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

  • {'armGroupLabels': ['SL-28 Low Dose'], 'description': 'Doses administered: 3×10\\^7 cells/injection, once daily, 5 days per week, 12 weeks.\n\nMode of administration: intravenous push', 'name': 'SL-28', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['SL-28 Intermediate Dose'], 'description': 'Doses administered: 6×10\\^7 cells/injection, once daily, 5 days per week, 12 weeks.\n\nMode of administration: intravenous push', 'name': 'SL-28', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])
  • {'armGroupLabels': ['SL-28 High Dose'], 'description': 'Doses administered: to-be-determeined-later Mode of administration: intravenous push', 'name': 'SL-28', 'type': 'BIOLOGICAL'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.